(Q35026045)

5 August 2017

1 reference

title

Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders (English)

1 reference

5 August 2017

0 references

1

Jaap M Middeldorp

1 reference

5 August 2017

4

Chris J L M Meijer

1 reference

5 August 2017

author name string

Antoinette A T P Brink

series ordinal

2

1 reference

5 August 2017

Adriaan J C van den Brule

series ordinal

3

1 reference

5 August 2017

publication date

1 January 2003

1 reference

Critical Reviews in Oncology Hematology

5 August 2017

published in

1 reference

5 August 2017

volume

45

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

1-36

1 reference

Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Mechanisms of chromosomal translocations in B cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Gastric lymphoma and Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Pathology of AIDS-related lymphomas and other AIDS-defining neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Circulating Epstein-Barr virus-carrying B cells in acute malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

THE ORIGIN OF HODGKIN AND REED/STERNBERG CELLS IN HODGKIN'S DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus is present in neoplastic cytotoxic T cells in extranodal, and predominantly in B cells in nodal T non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The multistep nature of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Genetic instabilities in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Detection of Epstein-Barr virus in invasive breast cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Re: detection of Epstein-Barr virus in invasive breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

No significant association of Epstein-Barr virus infection with invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Characterization of an Epstein-Barr virus receptor on human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Immunoglobulin A-Induced Shift of Epstein-Barr Virus Tissue Tropism

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Infectious mononucleosis-like response in common marmosets infected with Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Tissue specific distribution of Epstein-Barr virus (EBV) BZLF1 gene variants in nasopharyngeal carcinoma (NPC) bearing patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Multiprimed cDNA synthesis followed by PCR is the most suitable method for Epstein-Barr virus transcript analysis in small lymphoma biopsies.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Effects of expression of the Epstein-Barr virus small RNA EBER-1 in heterologous cells on protein synthesis and cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Activation of the interferon-inducible (2'-5') oligoadenylate synthetase by the Epstein-Barr virus RNA, EBER-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The role of EBERs in oncogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

An Epstein-Barr virus transcription unit is at least 84 kilobases long

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Transcription of Epstein-Barr virus-encoded nuclear antigen 1 promoter Qp is repressed by transforming growth factor-beta via Smad4 binding element in human BL cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Structure of the single-stranded-DNA-binding domain of replication protein A bound to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The DNA segregation mechanism of Epstein-Barr virus nuclear antigen 1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The budding yeast homolog of the human EBNA1-binding protein 2 (Ebp2p) is an essential nucleolar protein required for pre-rRNA processing

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Identification and molecular characterization of two diagnostically relevant marker proteins of the Epstein-Barr virus capsid antigen complex.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus latent gene expression during the initiation of B cell immortalization

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

EBNA-LP associates with cellular proteins including DNA-PK and HA95.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus nuclear antigen 5 interacts with HAX-1, a possible component of the B-cell receptor signalling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Modulation of vimentin, the CD40 activation antigen and Burkitt's lymphoma antigen (CD77) by the Epstein-Barr virus nuclear antigen EBNA-4.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2N, a major isoform of RBP-J kappa in B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Characterization of the transcriptional repressor RBP in Epstein-Barr virus-transformed B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus suppresses a G(2)/M checkpoint activated by genotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The latent membrane protein-1 in Epstein-Barr virus-transformed lymphoblastoid cells is found with ubiquitin-protein conjugates and heat-shock protein 70 in lysosomes oriented around the microtubule organizing centre

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Direct immunosuppressive effects of EBV-encoded latent membrane protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-kappaB activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Production monitoring and purification of EBV encoded latent membrane protein 1 expressed and secreted by recombinant baculovirus infected insect cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus gene expression in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Immunohistochemical demonstration of different latent membrane protein-1 epitopes of Epstein-Barr virus in lymphoproliferative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: relation between latent membrane protein-1 positivity and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus immortalization and latency

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

LMP1 structure and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

High Concentration of the EBV Latent Membrane Protein 1 in Glycosphingolipid-Rich Complexes from both Epithelial and Lymphoid Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Cytokine signaling and Epstein-Barr virus-mediated cell transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Hodgkin's disease: a tumor with disturbed immunological pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus latent membrane protein 2A has no growth-altering effects when expressed in differentiating epithelia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus: exploiting the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

EBV gene expression in an NPC-related tumour.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Structural analyses of the Epstein-Barr virus BamHI A transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

In vivo transcription of the Epstein-Barr virus (EBV) BamHI-A region without associated in vivo BARF0 protein expression in multiple EBV-associated disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

An Epstein-Barr virus protein interacts with Notch

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus complementary strand transcripts (CSTs/BARTs) and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus BamHi-a rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Characterization of the epstein-barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Early events in Epstein-Barr virus infection of human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Evolutionary conservation of function among mammalian, avian, and viral homologs of the Bcl-2 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

BHRF1 is highly conserved in primate virus analogues of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus and apoptosis: viral mimicry of cellular pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Evolving principles in immunopathology: interleukin 10 and its relationship to Epstein-Barr virus protein BCRF1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Paralysis of B7 co-stimulation through the effect of viral IL-10 on T cells as a mechanism of local tolerance induction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Interleukin-10 in Epstein-Barr virus-associated post-transplant lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr Virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappaB and different signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

B cell activation and the establishment of Epstein-Barr virus latency

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Persistence of the Entire Epstein-Barr Virus Genome Integrated into Human Lymphocyte DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Integrated and episomal forms of Epstein-Barr virus (EBV) in EBV associated disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus (EBV) in infectious mononucleosis: detection of the virus in tonsillar B lymphocytes but not in desquamated oropharyngeal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus: Co-opting B-cell memory and migration

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

A novel form of Epstein-Barr virus latency in normal B cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

EBV persistence involves strict selection of latently infected B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus: adaptation to a life within the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Human B cells immortalized with Epstein-Barr virus upregulate CCR6 and CCR10 and downregulate CXCR4 and CXCR5

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Detection of Epstein-Barr virus small RNAs in routine paraffin sections using non-isotopic RNA/RNA in situ hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of epstein-barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Nucleic acid sequence-based amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

A major DNA binding protein encoded by BALF2 open reading frame of Epstein-Barr virus (EBV) forms a complex with other EBV DNA-binding proteins: DNAase, EA-D, and DNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus gene expression in oral hairy leukoplakia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Mapping the X-linked lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Acquired Agammaglobulinemia after a Life-Threatening Illness with Clinical and Laboratory Features of Infectious Mononucleosis in Three Related Male Children

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Correction of Duncan's syndrome by allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

X-linked lymphoproliferative disease: twenty-five years after the discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Post-transplant malignancy: the role of immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The role of EBV in post-transplant malignancies: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of epstein-barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Feasibility of cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using haploidentical donors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

BCL-6 in Aids-Related Lymphomas: Pathogenetic and Histogenetic Implications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Malignant lymphoma in African children.I. A clinical syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus and its possible role in the pathogenesis of B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Evidence for local immunosuppression and demonstration of c-myc amplification in pyothorax-associated lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus and human T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Enteropathy-associated T-cell lymphomas have a cytotoxic T-cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: Implications for tumor immune escape mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Development of Epstein-Barr virus-associated B cell lymphoma after intensive treatment of patients with angioimmunoblastic lymphadenopathy with dysproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Prevalence of epstein‐barr virus DNA in different T‐cell lymphoma entities in a European population

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epidemiology of EBV and Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Gammaherpesviruses and "Hit-and-Run" oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystander

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Influence of Epstein-Barr virus genomes on patient survival in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

CD8(+) T cells in Hodgkin's disease tumor tissue are a polyclonal population with limited clonal expansion but little evidence of selection by antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Risk of cancer in migrants and their descendants in Israel: II. Carcinomas and germ-cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus and gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr viral genomes by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Presence of Epstein-Barr virus in lymphoepithelioma-like carcinoma of the middle ear.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Association of Epstein-Barr virus with thymic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

No direct role for Epstein-Barr virus in oral carcinogenesis: a study at the DNA, RNA and protein levels

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Prevalence of Epstein-Barr virus in the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein Barr virus in carcinoma of the cervix.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Absence of Epstein-Barr virus in carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Absence of in situ hybridization evidence for latent- or lytic-phase Epstein-Barr virus infection of preinvasive squamous lesions of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Individual tumors of multifocal EB virus-induced malignant lymphomas in tamarins arise from different B-cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Persistent Epstein-Barr virus infection in the common marmoset (Callithrix jacchus).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Expression of Epstein-Barr-virus-related nuclear antigens and B-cell markers in lymphomas of SIV-immunosuppressed monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

A monkey model for Epstein Barr virus-associated lymphomagenesis in human acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

An Epstein-Barr-related herpesvirus from marmoset lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

HV(MNE), a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

An animal model for acute and persistent Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Immunization of common marmosets with Epstein-Barr virus (EBV) envelope glycoprotein gp340: effect on viral shedding following EBV challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Structure and regulation of the blast-2/CD23 antigen in epithelial cells from nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

The BFRF1 gene of Epstein-Barr virus encodes a novel protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

fgr proto-oncogene mRNA induced in B lymphocytes by Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

A novel c-fgr exon utilized in Epstein-Barr virus-infected B lymphocytes but not in normal monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900078-1

7 January 2021

10.1016/S1040-8428(02)00078-1

Identifiers

DOI

1 reference

5 August 2017

1 reference